Molecular Partners AG (MOLN)
NASDAQ: MOLN
· Real-Time Price · USD
3.89
0.04 (1.04%)
At close: May 16, 2025, 3:59 PM
3.84
-1.29%
After-hours: May 16, 2025, 04:00 PM EDT
1.04% (1D)
| Bid | 3.37 |
| Market Cap | 143.44M |
| Revenue (ttm) | 4.97M |
| Net Income (ttm) | -54.04M |
| EPS (ttm) | -1.89 |
| PE Ratio (ttm) | -2.06 |
| Forward PE | -1.81 |
| Analyst | n/a |
| Ask | 3.9 |
| Volume | 166 |
| Avg. Volume (20D) | 10,758 |
| Open | 3.89 |
| Previous Close | 3.85 |
| Day's Range | 3.89 - 3.89 |
| 52-Week Range | 3.36 - 12.70 |
| Beta | 0.52 |
About MOLN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MOLN
Website n/a
3 weeks ago
+2.94%
Molecular Partners shares are trading higher after...
Unlock content with
Pro Subscription
6 months ago
+14.18%
Molecular Partners shares are trading higher after the company announced its radio-DARPin therapy candidate MP0712 was supported by in vivo data presented at the European Association of Nuclear Medicine Congress. The first-in-human start and initial clinical data are expected in 2025.
